BrainStorm Cell Therapeutics Inc (BCLI)

[condoe3]

https://www.cnbc.com/video/2020/04/03/past-outbreaks-history-pandemics-coronavirus-covid-19-squawk-box.html

Richard Preston is out with a new book called “Crisis in the Red Zone: The Story of the Deadliest Ebola Outbreak in History, and of the Outbreaks to Come.” He joins “Squawk Box” to discuss the coronavirus outbreak as the U.S. tries to figure out where we are in the curve.

This was about as informative an interview on the subject of Covid19
he mentions the Bioreactor method for creating antibodies

In 2014 Brainstorm and Octane successfully constructed a Bioreactor

NEW YORK, NY and PETACH TIKVAH, ISRAEL and KINGSTON, ON--(Marketwired - June 27, 2014) - BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, and Octane Biotech Inc., a Canadian firm that focuses on clinical systems for cell and tissue therapy, announced today that they have reached an important milestone in their technology collaboration, successfully constructing an Alpha prototype of a customized bioreactor for BrainStorm's NurOwn™ neurotrophic-factor secreting mesenchymal stem cells. The proprietary bioreactor under development will provide BrainStorm with large-scale manufacturing capabilities, enabling it to achieve economies of scale for its autologous stem cell product.

Octane and BrainStorm have successfully developed a sophisticated Alpha prototype of the NurOwn™ Bioreactor, utilizing a customized disposable cartridge that is dedicated to the intricacies of BrainStorm's NurOwn™ process. Operating within the Cocoon™ clinical delivery platform pioneered by Octane, the Alpha prototype automates the entire NurOwn™ process for unmatched process control and production economy. Based on this first working prototype, BrainStorm and Octane are quickly advancing to the next stage of system qualifications in anticipation of adopting all the benefits of cell production automation as quickly as possible for full clinical use